Kadimastem
Doron Birger's work experience includes serving as a Director at Kadimastem Ltd. since December 2020, Director at Pluri since July 2021, Chairman of the Board of Matricelf since December 2020, Chairman of the Board of Ultrasight Medical Imaging Ltd. since May 2019, Director at HeraMED Limited since December 2018, Director at Nurami Medical since March 2016, Chairman of the Board and interim CEO at Sight Diagnostics since April 2014, Board Member at IceCure Medical since August 2012, Chairman and CEO of Doron Birger Management and Consulting since May 2009, and Director at Vibrant Medical from June 2015 to April 2023.
From 1974 to 1978, Doron Birger attended the Hebrew University in Jerusalem. During this time, they pursued their M.A. degree in Economics, specializing in the field of Econometrics and Quantitative Economics.
This person is not in any teams
This person is not in any offices
Kadimastem
1 followers
Kadimastem is a clinical stage biotech company introducing a cutting-edge technology platform for the development, manufacturing, and bio-banking of functional human cells, providing off-the-shelf treatment for multiple indications.